Literature DB >> 6938236

The morphological classification of acute lymphoblastic leukaemia: concordance among observers and clinical correlations.

J M Bennett, D Catovsky, M T Daniel, G Flandrin, D A Galton, H R Gralnick, C Sultan.   

Abstract

The degree of concordance in the morphological classification of ALL was assessed by the FAB group after two successive reviews of 200 and 100 slides respectively. As a result, a simple scoring system for types L1 and L2 is proposed based on the following four features: (1) nuclear cytoplasmic ratio, (2) presence, prominence and frequency of nucleoli, (3) regularity of nuclear membrane outline, and (4) cell size. By this method, the overall concordance by seven observers (agreement of 7:0 or 6:1 only) increased from 63% to 84%. A significant difference in the incidence of the ALL morphological types in children (less than or equal to 15 years) and adults (greater than 15 years) was found: 74% of L1 cases were children while 66% of L2 cases were adults (P less than 0.001). No significant differences were observed in the incidence of L3 in children and adults or between L1 and L2 according to the membrane phenotype of the blast cells. All L3 cases had B-cell characteristics. A better prognosis for L1 and a higher relapse rate for L2 has been found in several recent reports; The present study may facilitate the morphological analysis of ongoing clinical trials in ALL by improving the reproducibility of the FAB classification.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6938236     DOI: 10.1111/j.1365-2141.1981.tb02684.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  38 in total

1.  Acute lymphoblastic leukaemia of the L3 subtype in adults in the Northern health region of England 1983-99.

Authors:  M R Velangi; M M Reid; N Bown; G H Jackson; G P Summerfield; S J Proctor; P R A Taylor
Journal:  J Clin Pathol       Date:  2002-08       Impact factor: 3.411

2.  CD56 expression in T-cell acute lymphoblastic leukemia is associated with non-thymic phenotype and resistance to induction therapy but no inferior survival after risk-adapted therapy.

Authors:  Lars Fischer; Nicola Gökbuget; Stefan Schwartz; Thomas Burmeister; Harald Rieder; Monika Brüggemann; Dieter Hoelzer; Eckhard Thiel
Journal:  Haematologica       Date:  2008-12-23       Impact factor: 9.941

3.  Heterogeneity of T cell lymphoblastic leukaemias.

Authors:  E Gómez; J F San Miguel; M González; A Orfao; C López-Berges; A Ríos; A López Borrasca
Journal:  J Clin Pathol       Date:  1991-08       Impact factor: 3.411

4.  A PCR-SSP method for detecting the His63Asp mutation in the HFE gene associated with hereditary haemochromatosis.

Authors:  D Smillie
Journal:  Mol Pathol       Date:  1998-08

5.  A simple combined microdissection and aspiration device for the rapid procurement of single cells from clinical peripheral blood smears.

Authors:  C P Beltinger; K M Debatin
Journal:  Mol Pathol       Date:  1998-08

6.  Treatment of adult acute lymphoblastic leukaemia using an intensive chemotherapy protocol.

Authors:  R Liang; T K Chan; G T Chan; D Todd
Journal:  Cancer Chemother Pharmacol       Date:  1989       Impact factor: 3.333

7.  Periodic acid Schiff reaction in childhood lymphoblastic leukaemia. The Medical Research Council Working Party on Childhood Leukaemia.

Authors:  J S Lilleyman; J A Britton; L M Anderson; S M Richards; C C Bailey; J M Chessells
Journal:  J Clin Pathol       Date:  1994-08       Impact factor: 3.411

8.  Granulocyte colony-stimulating factor (G-CSF) as an adjunct to induction chemotherapy of adult acute lymphoblastic leukemia (ALL).

Authors:  R Scherrer; K Geissler; P A Kyrle; H Gisslinger; U Jäger; P Bettelheim; K Laczika; G Locker; C Scholten; C Sillaber
Journal:  Ann Hematol       Date:  1993-06       Impact factor: 3.673

9.  Leukemic cell differentiation in childhood leukemias. Analysis by enzyme markers.

Authors:  G Gaedicke; H G Drexler
Journal:  Eur J Pediatr       Date:  1984-08       Impact factor: 3.183

10.  High Erk-1 activation and Gadd45a expression as prognostic markers in high risk pediatric haemolymphoproliferative diseases.

Authors:  Velia D'Angelo; Stefania Crisci; Fiorina Casale; Raffaele Addeo; Maria Giuliano; Elvira Pota; Paola Finsinger; Alfonso Baldi; Roberto Rondelli; Alberto Abbruzzese; Michele Caraglia; Paolo Indolfi
Journal:  J Exp Clin Cancer Res       Date:  2009-03-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.